{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:29:42Z","timestamp":1786703382218,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Postdoctoral Scientific Research Foundation, General Hospital of Central Theater Command","award":["2025BSH070"],"award-info":[{"award-number":["2025BSH070"]}]},{"name":"the National Natural Science Foundation of China General Program","award":["82471110"],"award-info":[{"award-number":["82471110"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-05089-w","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:14:47Z","timestamp":1786698887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of 1-year fibrosis in treatment-na\u00efve neovascular age-related macular degeneration: the role of baseline OCTA-derived MNV vessel density"],"prefix":"10.1186","volume":"26","author":[{"given":"Yi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianggui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9812-740X","authenticated-orcid":false,"given":"Yanping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"issue":"13","key":"5089_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.10.13.5","volume":"10","author":"PH Gabrielle","year":"2021","unstructured":"Gabrielle PH, Nguyen V, Arnold JJ, Bhandari S, Viola F, Tigchelaar-Besling OAM, et al. Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis. Translational Vis Sci Technol. 2021;10(13):5.","journal-title":"Translational Vis Sci Technol"},{"issue":"8","key":"5089_CR2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.oret.2020.02.011","volume":"4","author":"RN Khurana","year":"2020","unstructured":"Khurana RN, Chang L, Day BM, Ghanekar A, Stoilov I. Timing of Peak Vision Gains in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab. Ophthalmol Retina. 2020;4(8):760\u20136.","journal-title":"Ophthalmol Retina"},{"key":"5089_CR3","doi-asserted-by":"publisher","first-page":"100906","DOI":"10.1016\/j.preteyeres.2020.100906","volume":"82","author":"PS Mettu","year":"2021","unstructured":"Mettu PS, Allingham MJ, Cousins SW. Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities. Prog Retin Eye Res. 2021;82:100906.","journal-title":"Prog Retin Eye Res"},{"key":"5089_CR4","doi-asserted-by":"publisher","first-page":"106250","DOI":"10.1016\/j.nbd.2023.106250","volume":"185","author":"D Liu","year":"2023","unstructured":"Liu D, Zhang C, Zhang J, Xu GT, Zhang J. Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium. Neurobiol Dis. 2023;185:106250.","journal-title":"Neurobiol Dis"},{"key":"5089_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajo.2022.09.008","volume":"246","author":"KX Cheong","year":"2023","unstructured":"Cheong KX, Cheung CMG, Teo KYC. Review of Fibrosis in Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2023;246:192\u2013222.","journal-title":"Am J Ophthalmol"},{"key":"5089_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exer.2015.03.009","volume":"142","author":"K Ishikawa","year":"2016","unstructured":"Ishikawa K, Kannan R, Hinton DR. Molecular mechanisms of subretinal fibrosis in age-related macular degeneration. Exp Eye Res. 2016;142:19\u201325.","journal-title":"Exp Eye Res"},{"issue":"1","key":"5089_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12886-017-0544-x","volume":"17","author":"L Gonzalez-Buendia","year":"2017","unstructured":"Gonzalez-Buendia L, Delgado-Tirado S, Sanabria MR, Fernandez I, Coco RM. Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab. BMC Ophthalmol. 2017;17(1):147.","journal-title":"BMC Ophthalmol"},{"key":"5089_CR8","doi-asserted-by":"crossref","unstructured":"Ferro Desideri L, Traverso CE, Nicol\u00f2 M, Munk MR. Faricimab for the treatment of diabetic macular edema and neovascular age-related macular degeneration. Pharmaceutics. 2023;15(5).","DOI":"10.3390\/pharmaceutics15051413"},{"key":"5089_CR9","doi-asserted-by":"crossref","unstructured":"Shu DY, Butcher E, Saint-Geniez M. EMT and EndMT: emerging roles in age-related macular degeneration. Int J Mol Sci. 2020;21(12).","DOI":"10.3390\/ijms21124271"},{"issue":"7","key":"5089_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.ophtha.2018.01.004","volume":"125","author":"E Daniel","year":"2018","unstructured":"Daniel E, Pan W, Ying GS, Kim BJ, Grunwald JE, Ferris FL 3, et al. Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. 2018;125(7):1037\u201346.","journal-title":"Ophthalmology"},{"issue":"16","key":"5089_CR11","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1038\/s41433-024-03256-1","volume":"38","author":"E Gadiollet","year":"2024","unstructured":"Gadiollet E, Kodjikian L, Vasson F, Kodaday K, Chirpaz N, Wolff B, et al. Effect of baseline fluid localization on visual acuity and prognosis in type 1 macular neovascularization treated with anti-VEGF. Eye. 2024;38(16):3161\u20138.","journal-title":"Eye"},{"key":"5089_CR12","doi-asserted-by":"publisher","first-page":"1451726","DOI":"10.3389\/fmed.2024.1451726","volume":"11","author":"S Liu","year":"2024","unstructured":"Liu S, Zheng M, Sun H, Pan C, Li D, Zhou X, et al. Analysis of factors affecting prognosis of the visual acuity and baseline risk factors for subretinal fibrosis in neovascular age-related macular degeneration patients. Front Med. 2024;11:1451726.","journal-title":"Front Med"},{"issue":"1","key":"5089_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41598-021-03716-8","volume":"12","author":"PK Roberts","year":"2022","unstructured":"Roberts PK, Schranz M, Motschi A, Desissaire S, Hacker V, Pircher M, et al. Baseline predictors for subretinal fibrosis in neovascular age-related macular degeneration. Sci Rep. 2022;12(1):88.","journal-title":"Sci Rep"},{"issue":"4","key":"5089_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/aos.15309","volume":"101","author":"J S\u00e1nchez-Monroy","year":"2023","unstructured":"S\u00e1nchez-Monroy J, Nguyen V, Puzo M, Calvo P, Arruabarrena C, Monaco P, et al. Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registry. Acta Ophthalmol. 2023;101(4):457\u201364.","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"5089_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1167\/tvst.9.9.48","volume":"9","author":"A Arrigo","year":"2020","unstructured":"Arrigo A, Aragona E, Di Nunzio C, Bandello F, Parodi MB. Quantitative Optical Coherence Tomography Angiography Parameters in Type 1 Macular Neovascularization Secondary to Age-Related Macular Degeneration. Translational Vis Sci Technol. 2020;9(9):48.","journal-title":"Translational Vis Sci Technol"},{"issue":"5","key":"5089_CR16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00417-017-3588-y","volume":"255","author":"ML Farecki","year":"2017","unstructured":"Farecki ML, Gutfleisch M, Faatz H, Rothaus K, Heimes B, Spital G, et al. Characteristics of type 1 and 2 CNV in exudative AMD in OCT-Angiography. Graefe\u2019s archive Clin experimental Ophthalmol = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2017;255(5):913\u201321.","journal-title":"Graefe\u2019s archive Clin experimental Ophthalmol = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie"},{"key":"5089_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ajo.2023.03.033","volume":"252","author":"F Romano","year":"2023","unstructured":"Romano F, Cozzi E, Airaldi M, Nassisi M, Viola F, Aretti A, et al. Ten-Year Incidence of Fibrosis and Risk Factors for Its Development in Neovascular Age-Related Macular Degeneration. Am J Ophthalmol. 2023;252:170\u201381.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"5089_CR18","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1111\/aos.14905","volume":"100","author":"S Llorente-Gonz\u00e1lez","year":"2022","unstructured":"Llorente-Gonz\u00e1lez S, Hernandez M, Gonz\u00e1lez-Zamora J, Bilbao-Malav\u00e9 V, Fern\u00e1ndez-Robredo P, Saenz-de-Viteri M, et al. The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world. Acta Ophthalmol. 2022;100(2):e521\u201331.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"5089_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/bjo.87.5.609","volume":"87","author":"R Hogg","year":"2003","unstructured":"Hogg R, Curry E, Muldrew A, Winder J, Stevenson M, McClure M, et al. Identification of lesion components that influence visual function in age related macular degeneration. Br J Ophthalmol. 2003;87(5):609\u201314.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"5089_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.oret.2017.08.019","volume":"2","author":"G Casalino","year":"2018","unstructured":"Casalino G, Stevenson MR, Bandello F, Chakravarthy U. Tomographic Biomarkers Predicting Progression to Fibrosis in Treated Neovascular Age-Related Macular Degeneration: A Multimodal Imaging Study. Ophthalmol Retina. 2018;2(5):451\u201361.","journal-title":"Ophthalmol Retina"},{"key":"5089_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ajo.2020.01.012","volume":"213","author":"M Choi","year":"2020","unstructured":"Choi M, Kim SW, Yun C, Oh J. OCT Angiography Features of Neovascularization as Predictive Factors for Frequent Recurrence in Age-Related Macular Degeneration. Am J Ophthalmol. 2020;213:109\u201319.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"5089_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ophtha.2016.10.008","volume":"124","author":"WA Samara","year":"2017","unstructured":"Samara WA, Shahlaee A, Adam MK, Khan MA, Chiang A, Maguire JI, et al. Quantification of Diabetic Macular Ischemia Using Optical Coherence Tomography Angiography and Its Relationship with Visual Acuity. Ophthalmology. 2017;124(2):235\u201344.","journal-title":"Ophthalmology"},{"issue":"1","key":"5089_CR23","doi-asserted-by":"publisher","first-page":"18068","DOI":"10.1038\/s41598-021-97652-2","volume":"11","author":"CR Hsu","year":"2021","unstructured":"Hsu CR, Lai TT, Hsieh YT, Ho TC, Yang CM, Yang CH. Combined quantitative and qualitative optical coherence tomography angiography biomarkers for predicting active neovascular age-related macular degeneration. Sci Rep. 2021;11(1):18068.","journal-title":"Sci Rep"},{"issue":"1","key":"5089_CR24","first-page":"16","volume":"9","author":"J Jia","year":"2022","unstructured":"Jia J, Lu B, Zhao Z, Yu Y, Wang F, Zhou M, et al. Prediction of the short-term efficacy of anti-VEGF therapy for neovascular age-related macular degeneration using optical coherence tomography angiography. Eye Vis (London England). 2022;9(1):16.","journal-title":"Eye Vis (London England)"},{"issue":"2","key":"5089_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","volume":"126","author":"GJ Jaffe","year":"2019","unstructured":"Jaffe GJ, Ying GS, Toth CA, Daniel E, Grunwald JE, Martin DF, et al. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology. 2019;126(2):252\u201360.","journal-title":"Ophthalmology"},{"issue":"8","key":"5089_CR26","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaophthalmol.2014.1019","volume":"132","author":"GS Ying","year":"2014","unstructured":"Ying GS, Kim BJ, Maguire MG, Huang J, Daniel E, Jaffe GJ, et al. Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials. JAMA Ophthalmol. 2014;132(8):915\u201321.","journal-title":"JAMA Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-05089-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05089-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05089-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:40:43Z","timestamp":1786700443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-05089-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5089"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-05089-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Ethics Committee of the General Hospital of Central Theater Command (Approval No. 2024015-01) and adhered to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"493"}}